When the pharmaceutical producer has a lot of suppliers, then these suppliers also needs to be assessed by classifying them into distinct amounts dependent on their own impact on the medicinal merchandise.“We've had this crisis in China for at least seven months. Complete provinces have been shut down. And naturally we’ve experienced challenges